Webinar: Animal Models of Disease for Nonclinical Safety Assessment: Pharmaceutical Industry Survey, Dec. 6 at 11 am ET

The American College of Toxicology and the Society of Toxicologic Pathology in collaboration with the Teratology Society and British Toxicology Society will host a new webinar entitled "Animal Models of Disease for Nonclinical Safety Assessment: Pharmaceutical Industry Survey" on Wednesday, December 6, 2017, at 11:00 AM Eastern.

This webinar is free and open to the public. Advamce registration is required. Register HERE

Speaker: Sherry J. Morgan, DVM, PhD, ACVP, ABVT, ABT; Senior Research Fellow, AbbVie

Webinar Abstract: Considerations for the use of animal models of disease will be discussed with specific examples of organ systems and/or responses that are generally either well or poorly predicted with the use of conventional animal models. The results of a recent survey (IQ Focus Group) that queried the current practices as it pertains to the use of animal models in nonclinical safety assessment will be presented. Attention will be given to differentiating the use of animal models of disease in discovery vs. development as well as describing common themes across industry.

Register HERE for the live webinar on December 6. Several weeks after the live webinar a recording will be posted in the Educational Webinar File Library on BDR Connection for continued access by Teratology Society members.

Recent Stories
Announcing the New Teratology Society Innovator Award

FDA Launches Predictive Toxicology Roadmap

PODCAST: Secrets of the Human Brain Revealed: Development, Disease & the Zika Virus